CytRx Corporation announced that based on results from its 2021 Annual Meeting of Stockholders (the "Annual Meeting"), both of the Company’s Class III director candidates – Joel K. Caldwell, CPA and Jennifer K. Simpson, Ph.D. – have been elected to the Board of Directors. Jennifer K. Simpson, Ph.D. is the Chief Executive Officer and a Director of Panbela Therapeutics Inc.